Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec 5:6:168.
doi: 10.3389/fcimb.2016.00168. eCollection 2016.

The Cytolethal Distending Toxin Contributes to Microbial Virulence and Disease Pathogenesis by Acting As a Tri-Perditious Toxin

Affiliations
Review

The Cytolethal Distending Toxin Contributes to Microbial Virulence and Disease Pathogenesis by Acting As a Tri-Perditious Toxin

Monika D Scuron et al. Front Cell Infect Microbiol. .

Abstract

This review summarizes the current status and recent advances in our understanding of the role that the cytolethal distending toxin (Cdt) plays as a virulence factor in promoting disease by toxin-producing pathogens. A major focus of this review is on the relationship between structure and function of the individual subunits that comprise the AB2 Cdt holotoxin. In particular, we concentrate on the molecular mechanisms that characterize this toxin and which account for the ability of Cdt to intoxicate multiple cell types by utilizing a ubiquitous binding partner on the cell membrane. Furthermore, we propose a paradigm shift for the molecular mode of action by which the active Cdt subunit, CdtB, is able to block a key signaling cascade and thereby lead to outcomes based upon programming and the role of the phosphatidylinositol 3-kinase (PI-3K) in a variety of cells. Based upon the collective Cdt literature, we now propose that Cdt is a unique and potent virulence factor capable of acting as a tri-perditious toxin that impairs host defenses by: (1) disrupting epithelial barriers; (2) suppressing acquired immunity; (3) promoting pro-inflammatory responses. Thus, Cdt plays a key role in facilitating the early stages of infection and the later stages of disease progression by contributing to persistence and impairing host elimination.

Keywords: PI-3 kinase; epithelial cells; inflammation; lymphocytes; macrophages; toxin; virulence.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overview of Cdt's role as a virulence factor. Most Cdts are heterotrimeric AB2 toxins that are capable of affecting multiple cell types due to the ability of the binding (B) subunits to bind to cells via a common membrane moiety, cholesterol. Furthermore, the active (A) subunit, CdtB, functions as a PIP3 phosphatase and is therefore capable of inducing a blockade of a universally employed signaling cascade, PI-3K. We now propose that in its capacity as a virulence factor, Cdt functions as a tri-perditious toxin that is capable of impairing host defense in three ways: (1) induce cell cycle arrest and apoptosis in epithelial cells thereby altering epithelial barriers and facilitating infection by Cdt-producing pathogens; (2) induce cell cycle arrest and apoptosis in lymphocytes thereby impairing acquired immunity and promoting persistent infection; and (3) altering macrophage function leading to a pro-inflammatory response as a result of increased cytokine synthesis and inflammasome activation. Please note that we have not excluded the possibility that some Cdts and/or some cells may under some conditions be intoxicated as a result of CdtB associated DNase activity.
Figure 2
Figure 2
Structural similarity between the active sites of CdtB and IP5P. The superposition was based on conserved residues in the active sites of CdtB [blue; PDB code 2f2f_B (Yamada et al., 2006)] and IP5P [red; PDB code 1i9z_A (Tsujishita et al., 2001)]. The two sets of 6 conserved residues are aligned well, with an RMSD of 0.26 Å. Residue numbers correspond to CdtB structure. Parts of superimposed structures were clipped out of viewing plane for clarity.

References

    1. Abeck D., Freinkel A. L., Korting H. C., Szeimis R. M., Ballard R. C. (1997). Immunohistochemical investigations of genital ulcers caused by Haemophilus ducreyi. Int. J. STD AIDS 8, 585–588. 10.1258/0956462971920839 - DOI - PubMed
    1. Acik M. N., Karahan M., Ongor H., Cetinkaya B. (2013). Investigation of virulence and cytolethal distending toxin genes in Campylobacter spp. isolated from sheep in Turkey. Foodborne Pathog. Dis. 10, 589–594. 10.1089/fpd.2012.1447 - DOI - PubMed
    1. Ahmed H. J., Svensson L. A., Cope L. D., Latimer J. L., Hansen E. J., Ahlman K., et al. (2001). Prevalence of cdtABC genes encoding cytolethal distending toxin among Haemophilus ducreyi and Actinobacillus actinomycetemcomitans strains. J. Med. Microbiol. 50, 860–864. 10.1099/0022-1317-50-10-860 - DOI - PubMed
    1. Akifusa S., Poole S., Lewthwaite J., Henderson B., Nair S. P. (2001). Recombinant Actinobacillus actinomycetemcomitans cytolethal distending toxin proteins are required to interact to inhibit human cell cycle progression and to stimulate human leukocyte cytokine synthesis. Infect. Immun. 69, 5925–5930. 10.1128/IAI.69.9.5925-5930.2001 - DOI - PMC - PubMed
    1. Albert M. J., Faruque S. M., Faruque A. S., Bettelheim K. A., Keogi P. K., Bhuiyan N. A., et al. (1996). Controlled study of cytolethal distending toxin-producing Escherichia coli infections in Bangladeshi children. J. Clin. Microbiol. 34, 717–719. - PMC - PubMed

Publication types

MeSH terms